US adds Merck pill as 2nd easy-to-use drug against COVID-19
Dr. Nick Kartsonis, Merck's senior vice president of clinical research, said company scientists are still studying the drug and they hope to eventually get it approved for use in children.
|
December 23, 2021 10:15 AM
By MATTHEW PERRONE
AP Health Writer
WASHINGTON — U.S...
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
